IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.45
+9.85%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -1.00x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 3.76x
Liquidity & coverage
- Current ratio
- 8.22x
- Quick ratio
- 8.22x
- Cash ratio
- 7.88x
- Interest coverage
- -610.45x
- EBITDA / interest
- -645.62x
- Working capital
- $162.9M
Cash & dividend
- FCF / debt
- -28.77x
- Cash flow / debt
- -28.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026